HOTH
Hoth Therapeutics Inc
NASDAQ: HOTH · HEALTHCARE · BIOTECHNOLOGY
$0.71
-2.70% today
Updated 2026-04-29
Market cap
$13.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$0 – $2
Volume
3.1M
Hoth Therapeutics Inc (HOTH) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.23M | $503916.00 | $2.84M | $5.24M | $10.99M | $6.76M | $10.24M | $7.71M |
| Cash & equivalents | $1.23M | $282621.00 | $1.69M | $2.63M | $8.54M | $6.43M | $9.29M | $7.04M |
| Current assets | $1.23M | $501648.00 | $2.64M | $4.78M | $10.58M | $6.73M | $10.15M | $7.64M |
| Total liabilities | $49466.00 | $348951.00 | $440121.00 | $597149.00 | $1.10M | $1.64M | $704983.00 | $833906.00 |
| Current liabilities | $49466.00 | $348951.00 | $440121.00 | $312149.00 | $867787.00 | $1.39M | $678657.00 | $831197.00 |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | $1.18M | $154965.00 | $2.40M | $4.65M | $9.88M | $5.12M | $9.54M | $6.88M |
| Retained earnings | $-2.02M | $-4.51M | $-12.22M | $-19.41M | $-33.73M | $-45.10M | $-52.22M | $-60.41M |
| Accounts receivable | — | — | — | — | $50000.00 | — | $46769.00 | $46769.00 |
| Inventory | — | — | — | — | $-93.88M | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |